AbbVie: Strong Cash Flow Growth Fuels Dividend Growth

vzphotos Business Overview AbbVie Inc. (NYSE:ABBV) is a pharmaceutical with a strong history of growth and generating income for investors. In addition to having a number of highly lucrative products in the market such as Skyrizi and Rinvoq, the company also enjoys a pretty robust pipeline of many products in a variety of phases of development in several fields including oncology, immunology, and neuroscience. In 2025, the company expects to obtain FDA approval for a variety of products including Rinvoq for ...